|
Summary Information: Merus N.V. Common Shares NASDAQ:MRUS |
  admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Merus is a clinical-stage oncology company developing innovative full-length human bispecific and trispecific antibody therapeutics, referred to as Multiclonics®. Multiclonics® are manufactured using industry standard processes and have been observed in preclinical and clinical studies to have several of the same features of conventional human monoclonal antibodies, such as long half-life and low immunogenicity.
__The following are links to various summary and news pages for __Merus N.V. Common Shares [ MRUS ]. __Note: Some Links might not have information for the company. |
|